Clinical trial
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic…
NCT00209677 · Hokkaido Gastrointestinal Cancer Study Group, Other · Suspended
Key facts
| NCT number | NCT00209677 |
|---|---|
| Title | Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer |
| Official title | Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer |
| Lead sponsor | Hokkaido Gastrointestinal Cancer Study Group, Other |
| Collaborators | Hokkaido University Hospital |
| Status | Suspended |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine, S-1 |
| Enrollment | 40 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 1, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: